UGA Biopharma
Business Services · Germany · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Neuendorfstraße 20a, Hennigsdorf, Brande...Phone Number
+49 33022024900Website
www.ugabiopharma.comRevenue
$6.1 MillionIndustry
About UGA Biopharma
Is UGA Biopharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if UGA Biopharma has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on UGA Biopharma recently announced quarterly report
Click to see if UGA Biopharma had a recent Job posting/layoffs
Check out if UGA Biopharma is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at UGA Biopharma
Funding: Get notified immidiatlly once UGA Biopharma has new funding data
Product Launch: Get notified when UGA Biopharma launches new products
Website visits: Recent activity has been detected on your website
UGA Biopharma, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined UGA Biopharma as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
UGA Biopharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
UGA Biopharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about UGA Biopharma.
UGA Biopharma Tech Stack
A closer look at the technologies used by UGA Biopharma
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding UGA Biopharma
UGA Biopharma specializes in the development of monoclonal cell lines for the production of advanced biologics and biosimilars. They offer a range of services including cell line development, upstream and downstream processing, and analytical method development. Their product portfolio features ready-to-use cell lines and proprietary CHO Prime medi... Read More